Abstract:Insulin-like growth factors (IGFs), along with their receptors and binding proteins, play key roles in human cell proliferation, differentiation and apoptosis. There is now substantial evidence suggesting that the IGF system is involved in the pathogenesis and progression of various malignancies. Recent studies have shown that targeting of the IGF-1 receptor (IGF-1R) signaling pathway might be a novel approach for the treatment of cancer. Presently numerous agents featuring different mechanisms of IGF targeting methods such as IGF-1R monoclonal antibodies, IGF-1R tyrosine kinase inhibitors and IGF ligand specific antibodies are being investigated in more than 170 clinical trials and appear to have potential therapeutic efficacy. However, advanced trials reiterate the importance of predictive biomarkers to guide the clinical efforts of these agents. As a result, current research strategies are emerging to identify the most suitable subpopulations of patients that might benefit from these treatments. Furthermore, newly presented toxicity and growth hormone response and implication of hybrid receptors in IGF signaling pathway pose unprecedented challenges in the design and application of anti-IGF agents. On the other hand, cross-talk in downstream signaling between IGF-1R and other tumor promoting pathways and the development of multi-target agents might encourage the IGF-1R-targeted therapies further into comprehensive treatments of cancer. With both challenges and prospects ahead, this paper reviewed the progress in this particular field.

Advance on insulin-like growth factor binding protein in human malignant tumors

Igfbp, A Novel Target of Lung Cancer?

Insulin-like growth factor binding protein-related protein 1 and cancer.

Research Progress of Insulin-Like Growth Factor Binding Protein IGFBP-3

Insulin - like growth factor type 1 receptor and malignancy:An update

The Roles of Insulin-Like Growth Factor Binding Protein Family in Development and Diseases

Insulin-Like Growth Factor Binding Protein-1 Inhibits Cancer Cell Invasion And Is Associated With Poor Prognosis In Hepatocellular Carcinoma

The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas

IGFBPs and Insulin Resistance

Pan-cancer Analysis of Oncogenic Role of Insulin-Like Growth Factor-Binding Proteins and Validation in Ovarian Cancer.

Expression characteristics and their functional role of IGFBP gene family in pan-cancer

Advances in Targeting Insulin-Like Growth Factor Signaling Pathway in Cancer Treatment.

Insulin Growth Factor Binding Protein 7 (Igfbp7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk

Research Progress on Physiological Function and Expression Regulation of Insulin-Like Growth Factor-Binding Protein-1

Insulin-like growth factor-1,insulin-like growth factor-1 receptor and prostate cancer

Assessment of Insulin-Like Growth Factors and Mutagen Sensitivity As Predictors of Lung Cancer Risk.

Studies on the interaction of insulin-like growth factor and binding protein

IGFBP2: Integrative Hub of Developmental and Oncogenic Signaling Network

Insulin-like Growth Factors and Dermatosis

Regulation of the insulin-like growth factor- Ⅰ on animal growth and development

Summary of The Study on Structure and Function of Insulin-Like Growth Factor-Binding Proteins